In this article, we will list the 5 Best Small Cap US Stocks to Buy. Please visit 8 Best Small Cap US Stocks to Buy if you would like to see the extended list and the methodology behind it.
Pixabay/Public Domain
5. Pediatrix Medical Group, Inc. (NYSE:MD)
On May 5, 2026, Pediatrix Medical Group, Inc. (NYSE:MD) reported Q1 adjusted EPS of 44c, versus the consensus estimate of 38c. Revenue totaled $476M, versus the consensus estimate of $465.82M. Same-unit revenue from net reimbursement-related factors increased 4.4% year over year. CEO Mark Ordan said first-quarter operating results exceeded expectations, driven by top-line growth, while adding that the company’s priorities for 2026 remain centered on supporting hospital partners through quality-focused care delivery. Ordan also said Pediatrix believes its strong cash flow generation and balance sheet position the company to pursue additional opportunities moving forward. Pediatrix Medical Group, Inc. (NYSE:MD) reaffirmed its FY26 adjusted EBITDA outlook of $280M-$300M.
On April 20, 2026, Jefferies analyst Jack Slevin raised the firm’s price target on Pediatrix Medical Group, Inc. (NYSE:MD) to $27 from $24 while maintaining a Buy rating. The firm said recent underperformance across healthcare services stocks reflected investor concerns tied to Q1 patient volumes, though Jefferies questioned whether consensus expectations fully accounted for weather-related disruptions caused by winter storms in Southern and East Coast markets.
Meanwhile, Truist raised the firm’s price target on Pediatrix Medical Group, Inc. (NYSE:MD) to $23 from $21 while maintaining a Hold rating as part of a broader preview of healthcare services earnings. Truist said it remains constructive on the sector given strong demand trends, supportive reimbursement conditions, defensive characteristics, and continued benefits tied to AI, automation, and connectivity initiatives.
Pediatrix Medical Group, Inc. (NYSE:MD) provides newborn, maternal-fetal, and pediatric subspecialty healthcare services in the United States.
4. Walker & Dunlop, Inc. (NYSE:WD)
On May 8, 2026, Keefe Bruyette raised the firm’s price target on Walker & Dunlop, Inc. (NYSE:WD) to $67 from $65 while maintaining an Outperform rating on the shares.
A day earlier, Walker & Dunlop, Inc. (NYSE:WD) reported Q1 adjusted core EPS of $1.02, versus the consensus estimate of 54c. Revenue totaled $301.3M, versus the consensus estimate of $269.07M. Chairman and CEO Willy Walker said the company’s strong first-quarter transaction volumes and earnings reflected the strength of the W&D team, brand, and position within commercial real estate capital markets. Walker added that robust financing activity drove strong quarterly transaction fees, which, together with recurring servicing and asset management fees, supported solid quarterly earnings as the company pursues its annual and long-term financial targets.
On April 23, 2026, Stephens initiated coverage of Walker & Dunlop, Inc. (NYSE:WD) with an Overweight rating and a $69 price target. The firm said it favors real estate finance companies with lower cyclicality and the ability to generate consistent earnings growth across market cycles, adding that Walker & Dunlop’s servicing and asset management segment contributes to a more balanced business model. Stephens also described the stock’s valuation discount as an attractive entry point.
Walker & Dunlop, Inc. (NYSE:WD), through its subsidiaries, originates, sells, and services multifamily and commercial real estate financing products and services in the United States.
3. Innovex International, Inc. (NYSE:INVX)
On May 6, 2026, Citi initiated coverage of Innovex International, Inc. (NYSE:INVX) with a Buy rating and a $35 price target. The firm said it views the company favorably due to its lower cyclicality and robust free cash flow conversion relative to oilfield service peers, while also believing Innovex can continue gaining market share across its end markets.
On May 4, 2026, Innovex International, Inc. (NYSE:INVX) reported Q1 revenue of $239M, down 1% year over year. CEO Adam Anderson said the company delivered a strong start to 2026, with both revenue and adjusted EBITDA exceeding the high end of guidance. Anderson said results benefited from operational execution, new product launches, cross-selling activity, favorable product mix, and earlier-than-expected gains from the exit of the legacy Eldridge facility. Anderson added that the quarter reinforced management’s view that the company’s subsea businesses can generate margins above 20% under its capital-light operating model.
The company also said it completed the acquisition of DIS during the quarter, adding production technologies that complement its portfolio and strengthen its offshore U.S. market position. Anderson added that Innovex continues gaining share through innovation, service quality, and the scale of its integrated platform, which management believes supports durable and profitable growth.
Innovex International, Inc. (NYSE:INVX) expects Q2 revenue of $235M-$245M and adjusted EBITDA of $43M-$48M.
Innovex International, Inc. (NYSE:INVX) designs, manufactures, sells, and rents engineered products for the oil and natural gas industry globally.
2. Adient plc (NYSE:ADNT)
On May 7, 2026, Deutsche Bank raised the firm’s price target on Adient plc (NYSE:ADNT) to $31 from $30 while maintaining a Buy rating on the shares. Stifel analyst Nathan Jones also raised the firm’s price target on Adient plc (NYSE:ADNT) to $28 from $26 and kept a Buy rating.
On May 6, 2026, Adient plc (NYSE:ADNT) reported Q2 adjusted EPS of 52c, versus the consensus estimate of 44c. Revenue totaled $3.87B, versus the consensus estimate of $3.63B. The company said it delivered solid quarterly results while continuing to execute with discipline in what it described as a dynamic operating environment. Management added that teams remained focused on supporting customers, maintaining operational execution, and driving growth initiatives.
Adient plc (NYSE:ADNT) raised its FY26 revenue outlook to $14.8B from $14.6B, versus the consensus estimate of $14.63B. The company also raised its FY26 adjusted EBITDA outlook to $885M from $880M and increased its free cash flow outlook to $130M from $125M, while maintaining its capital expenditures forecast of $300M. The company said its stronger first-half execution and ability to navigate external headwinds supported the decision to raise full-year guidance. Management also said Adient continues to maintain a strong balance sheet and liquidity position as it focuses on operational execution, regional growth, and margin expansion.
Adient plc (NYSE:ADNT) designs, develops, manufactures, and markets seating systems and components for passenger cars, commercial vehicles, and light trucks.
1. Spectrum Brands Holdings, Inc. (NYSE:SPB)
On May 8, 2026, Canaccord raised the firm’s price target on Spectrum Brands Holdings, Inc. (NYSE:SPB) to $100 from $94 and kept a Buy rating on the shares. The firm said Spectrum Brands delivered solid Q2 results, with sales coming in about 5% above consensus, while adjusted EBITDA and adjusted EPS were both roughly 23% ahead of expectations, led by strength in the Home & Garden segment.
A day earlier, Spectrum Brands Holdings, Inc. (NYSE:SPB) reported Q2 adjusted EPS of $1.25, versus the consensus estimate of $1.06. Revenue totaled $708.9M, versus the consensus estimate of $677.4M. Chairman and CEO David Maura said the company returned to top-line growth for the first time since the first quarter of fiscal 2025, supported by continued outperformance from key brands in the Global Pet Care and Home & Garden businesses, driven by innovation and distribution gains. Maura added that while Home & Personal Care sales declined, adjusted EBITDA improved due to actions taken over the past year, which management believes reinforces the effectiveness of its strategic initiatives.
Spectrum Brands Holdings, Inc. (NYSE:SPB) said it now expects fiscal 2026 adjusted EBITDA growth in the low-to-mid single-digit range while maintaining its outlook for flat to low single-digit net sales growth. The company also said adjusted free cash flow is expected to equal approximately 50% of adjusted EBITDA.
Spectrum Brands Holdings, Inc. (NYSE:SPB) operates as a branded consumer products and home essentials company across North America, Europe, the Middle East, Africa, Latin America, and Asia-Pacific.
While we acknowledge the potential of SPB to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SPB and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 10 AI Stocks with Potential to Rise 1000 Percent and 10 Best AI Pick-and-Shovel Stocks to Buy
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
